← Leaderboards
Jeffrey J. Saucerman
University Of Virginia
$6,548,663
Attributed
$11,838,989
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,838,989 · 6
By mechanism
R01$11,838,989 · 6
Top collaborators
- Matthew J Wolf5 shared
- Jeffrey W Holmes4 shared
- Johannes (Jop) Van Berlo4 shared
- Antonio Abbate2 shared
- Stefano Toldo2 shared
- Jennifer Michelle Davis1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Imre Noth$12,167,659
- John S Kim$1,503,057
- Johannes (jop) Van Berlo$5,718,429
- Ki Ho Park$621,957
- Emily R Mercadante$95,450
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionInnovationHeartRegulationHeart FailurePathway InteractionsTherapeutic TargetInsightIn VivoCellsCardiac MyocytesNetwork ModelsOrganAmericanResponseCardiacMolecularComputer ModelsMyocardiumIn VitroLifeExperimental StudyExperimental ModelsProteins
Grant awards (21)
Modeling of cell-specific LRP1 signaling in acute myocardial infarction$784,046
R01 · FY2025 · HL · contact PI
Systems Pharmacology Model of Cardiac Hypertrophy$761,655
R01 · FY2025 · HL · contact PI
Modeling intra- and inter-cellular networks for TRPC6-dependent cardiac fibrosis$726,452
R01 · FY2025 · HL · contact PI
Computational and Experimental Modeling of Cardiomyocyte Proliferation$684,665
R01 · FY2025 · HL · contact PI
Modeling of cell-specific LRP1 signaling in acute myocardial infarction$784,046
R01 · FY2024 · HL · contact PI
Systems Pharmacology Model of Cardiac Hypertrophy$746,423
R01 · FY2024 · HL · contact PI
Computational and Experimental Modeling of Cardiomyocyte Proliferation$673,705
R01 · FY2024 · HL · contact PI
Diversity Supplement: Systems Pharmacology Model of Cardiac Hypertrophy$50,330
R01 · FY2024 · HL · contact PI
Systems Pharmacology Model of Cardiac Hypertrophy$761,655
R01 · FY2023 · HL · contact PI
Computational and Experimental Modeling of Cardiomyocyte Proliferation$690,245
R01 · FY2023 · HL · contact PI
Systems Pharmacology Model of Cardiac Hypertrophy$761,655
R01 · FY2022 · HL · contact PI
Computational and Experimental Modeling of Cardiomyocyte Proliferation$709,107
R01 · FY2022 · HL · contact PI
Systems Pharmacology Model for Spatial Control of Cardiac Fibrosis$481,612
R01 · FY2020 · HL · contact PI
Systems Pharmacology Model for Spatial Control of Cardiac Fibrosis$481,419
R01 · FY2019 · HL · contact PI
Systems Pharmacology Model for Spatial Control of Cardiac Fibrosis$481,235
R01 · FY2018 · HL · contact PI
Systems Pharmacology Model for Spatial Control of Cardiac Fibrosis$479,704
R01 · FY2017 · HL · contact PI
Quantitative analysis of cAMP compartmentation in heart$313,173
R01 · FY2013 · HL · contact PI
Quantitative analysis of cAMP compartmentation in heart$329,505
R01 · FY2012 · HL · contact PI
Quantitative analysis of cAMP compartmentation in heart$328,342
R01 · FY2011 · HL · contact PI
Quantitative analysis of cAMP compartmentation in heart$405,303
R01 · FY2010 · HL · contact PI
Quantitative analysis of cAMP compartmentation in heart$404,712
R01 · FY2009 · HL · contact PI